aFraxis Lands $1,200,000 New Financing Round

  • Feed Type
  • Date
    5/16/2010
  • Company Name
    aFraxis
  • Mailing Address
    5626 Oberlin Dr. San Diego, CA 92121
  • Company Description
    Afraxis is discovering and developing drugs to treat diseases of the central nervous system, including schizophrenia, Alzheimer’s disease, Fragile X syndrome and autism spectrum disorders. Recent scientific discoveries have linked these disorders to underlying defects in the development and function of specialized structures of the neural synapse, called dendritic spines.
  • Website
    http://www.Afraxis.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,200,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.